Natingor, Marylyne B.
HRN: 26-00-09 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2024
CEFTRIAXONE 1G (VIAL)
10/04/2024
10/10/2024
IV
2g
OD
Infected Breast Mass
Waiting Final Action